AllianceBernstein’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$683K Sell
25,760
-1,013,657
-98% -$26.9M ﹤0.01% 2482
2025
Q1
$25.1M Sell
1,039,417
-75,651
-7% -$1.83M 0.01% 808
2024
Q4
$44.9M Buy
1,115,068
+81,183
+8% +$3.27M 0.02% 628
2024
Q3
$65.5M Sell
1,033,885
-207,240
-17% -$13.1M 0.02% 535
2024
Q2
$65.8M Sell
1,241,125
-319,753
-20% -$17M 0.02% 527
2024
Q1
$128M Sell
1,560,878
-2,113,057
-58% -$173M 0.05% 334
2023
Q4
$68.4M Buy
3,673,935
+123,861
+3% +$2.31M 0.03% 507
2023
Q3
$39.3M Buy
3,550,074
+588,513
+20% +$6.51M 0.02% 626
2023
Q2
$48M Buy
2,961,561
+2,947,905
+21,587% +$47.8M 0.02% 588
2023
Q1
$227K Buy
+13,656
New +$227K ﹤0.01% 2869
2022
Q2
Sell
-79,600
Closed -$239K 3375
2022
Q1
$239K Buy
79,600
+200
+0.3% +$601 ﹤0.01% 2941
2021
Q4
$365K Hold
79,400
﹤0.01% 2863
2021
Q3
$499K Hold
79,400
﹤0.01% 2748
2021
Q2
$476K Buy
79,400
+14,400
+22% +$86.3K ﹤0.01% 2822
2021
Q1
$411K Sell
65,000
-12,200
-16% -$77.1K ﹤0.01% 2743
2020
Q4
$435K Hold
77,200
﹤0.01% 2646
2020
Q3
$449K Sell
77,200
-2,500
-3% -$14.5K ﹤0.01% 2569
2020
Q2
$575K Sell
79,700
-3,900
-5% -$28.1K ﹤0.01% 2504
2020
Q1
$391K Buy
83,600
+13,300
+19% +$62.2K ﹤0.01% 2471
2019
Q4
$564K Hold
70,300
﹤0.01% 2493
2019
Q3
$484K Hold
70,300
﹤0.01% 2554
2019
Q2
$583K Hold
70,300
﹤0.01% 2533
2019
Q1
$699K Buy
70,300
+4,000
+6% +$39.8K ﹤0.01% 2401
2018
Q4
$507K Buy
66,300
+2,500
+4% +$19.1K ﹤0.01% 2467
2018
Q3
$1.11M Hold
63,800
﹤0.01% 2268
2018
Q2
$605K Buy
+63,800
New +$605K ﹤0.01% 2535